Table 2. Study Procedure and Checklist

Phase	Screening	Treatment
Visit	Screening visit	Visit 1(Baseline)	Visit 2(Final)
Time	2 weeks before-Week 0	Week 0	2 weeks after
Written consent	●
Sociodemographic information	●
Medical history	●
Medication history	●	●	●
Eligibility criteria	●
Random allocation		●
Anthropometry	●
Vital signs	●	●	●
The Hanifin and Rajka criteria	●	●
Photographing test lesions		●	●
L-SCORAD index		●	●
IGA scale		●	●
SCORAD index		●	●
DLQI		●	●
Pruritus VAS		●	●
Dryness VAS		●	●
Skin hydration		●	●
TEWL		●	●
Visit guide	●	●
Provide experimental products		●
Withdraw offered products			●
Compliance assessment			●
Adverse events			●
Satisfaction survey			●

L-SCORAD: Local Scoring Atopic Dermatitis, IGA: Investigator’s Global Assessment, SCORAD: Scoring Atopic Dermatitis, DLQI: Dermatology Life Quality Index, VAS: visual analog scale, and TEWL: transepidermal water loss